“Effectiveness and Safety After a Switch to Tildrakizumab: A Real World Multicenter Italian Study in Psoriasis”. Dermatology Practical & Conceptual, vol. 13, no. 4, Oct. 2023, p. e2023215, https://doi.org/10.5826/dpc.1304a215.